New research from BIDMC and Stanford reveals how nasal polyps form in chronic sinusitis, offering hope for improved care and treatment options. Read more.
BIDMC names Stuart J. Schnitt, MD, and Muneeb Ahmed, MD, to lead new cancer pathology and radiology divisions, advancing precision cancer care with Dana-Farber.
All Thing Celiac Webinar' on February 26 will discuss the link between certain cardiovascular diseases and individuals with celiac disease.
BIDMC scientists developed a trivalent mRNA TB vaccine that outperformed the old BCG shot in mice and is moving toward Phase 1 human trials.
Hemorrhoids are among the most frequent gastrointestinal complaints in the United States, sending millions of people to clinics and emergency rooms each year and costing the health system hundreds of ...
BOSTON – Beth Israel Deaconess Medical Center (BIDMC) has been named by U.S. News & World Report a 2025-2026 Best Hospital. BIDMC was ranked among the top 50 hospitals nationwide in nine adult ...
Following State and City Approvals, New Cancer Hospital and Clinical Collaboration Enters Next Phase
BOSTON – With the recent completion of a multi-agency, state and city regulatory process, the clinical collaboration among Dana-Farber Cancer Institute (Dana-Farber), Beth Israel Deaconess Medical ...
Approval Paves the Way for Construction of the Region’s Only Freestanding Inpatient Cancer Hospital and the Dana-Farber Beth Israel Deaconess Cancer Collaboration BOSTON – The Boston Planning and ...
This statement was originally issued jointly with Dana-Farber Cancer Institute and Harvard Medical Faculty Physicians. It is republished here to keep our patients, providers, and community informed of ...
Researchers at BIDMC Found Physicians Using Chatbots Spent More Time on Patient Cases and Made Safer Decisions Compared to Colleagues Without AI Access “Early implementation of AI into healthcare has ...
In a new analysis of national data, researchers at the Richard A. and Susan F. Smith Center for Outcomes Research at Beth Israel Deaconess Medical Center (BIDMC) estimated that 137 million U.S. adults ...
First-of-its-kind Trial in US Shows Drug-coated Balloons are a Superior Treatment Option for Patients Undergoing Coronary Angioplasty BOSTON – In the largest randomized clinical trial and first of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback